Public Release: 

Advancing Neurodegeneration Drug Discovery and Development

An interdisciplinary meeting explores what we can learn from cancer to advance new therapeutic development for neurodegenerative diseases

New York Academy of Sciences

EVENT: Learning from Cancer to Advance Neurodegeneration Drug Discovery and Development

Presented by the New York Academy of Sciences' Brain Dysfunction Discussion Group and the Alzheimer's Drug Discovery Foundation

DATE: Thursday, June 11, 2015 | 8:00 AM - 5:00 PM (reception to follow)

LOCATION: The New York Academy of Sciences, New York, NY

EVENT WEBSITE: http://www.nyas.org/NDDCancer

DESCRIPTION: Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegeneration? This interdisciplinary meeting seeks to answer these questions and help attendees learn from the mechanistic insight and years of research on cancer biology to advance new therapeutic development for neurodegenerative diseases. Speakers will address how their research relates to both cancer and neurodegeneration and what we can learn about cell biology and function from these seemingly disparate diseases. Talks will also discuss cancer drug repurposing opportunities for Alzheimer's and related dementias.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.